{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.28 vs. cons $2.20",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~4.3% vs. cons 4.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core adjusted EBITDA margin",
      "prediction": "BEAT",
      "answer": "pred ~15.5% vs. cons 15.2%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 core constant-currency revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~4.2% vs. cons 4.0% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2026 adjusted EPS growth",
      "prediction": "BETTER",
      "answer": "guide ~13.0% vs. cons 11.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2026 cost-reduction synergies",
      "prediction": "BETTER",
      "answer": "guide ~$950M vs. cons $900M (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 4.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 7.2,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "~4.8% day-1 residual expands to ~7.2% over five days because an organic-growth beat and higher ~13.0% FY2026 EPS framework versus ~11.5% consensus should drive upward out-period estimates; better ~ $950M synergy delivery versus ~$900M supports durable margin and buyback-driven EPS revisions rather than a one-quarter-only beat.",
  "day5_confidence": "MEDIUM"
}